Compare stocks

Evaluate stocks side by side, to find the best fit for your investment goals.
Revenio Group Oyj is a company focused on providing medical diagnostic solutions, primarily in the fields of ophthalmology. It is known for its innovative products, such as tonometers for eye pressure measurements, which are important in glaucoma examinations. Founded in Finland, the company has its headquarters in Vantaa. Revenio leverages its specialized expertise in medical technology to address specific healthcare needs, with a strategic focus on precision, reliability, and ease of use in its devices. The company's geographic footprint extends across multiple international markets, facilitated by a network of distributors and partners.
View stock
VS
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
View stock

Stock highlights

Stock comparison highlights
Stock name
Revenio Group OyjEli Lilly
Last price
€10.59$1,273.46
Currency
EUR
USD
€445M$1.2T
21.5043.86
€0.49$29.79
0.880.45
0$6.69
00.53%
Sector
HealthHealth
Employees
76550,000
Ticker
€REG1V$LLY
Primary listing
XHELNYSE

Performance

CumulativeRolling yearsLump sum investment

Invest in €REG1V or $LLY on Lightyear

Save on broker fees and invest in 6000+ stocks and funds. When you invest, your capital is at risk.